During a 10 year study period 234 patients were admitted on 371 occasions with a total of 566 acute variceal bleeding episodes. Of these, 173 patients had 343 variceal bleeds which required balloon tamponade to achieve initial control of bleeding during 229 admissions and were then referred for emergency injection sclerotherapy. Sixty-eight percent of these patients had alcoholic cirrhosis and 42% were poor risk Grade C patients. Injection sclerotherapy was performed initially using the rigid Negus oesophagoscope under general anaesthesia and later using the fibreoptic endoscope under light sedation. Definitive control of variceal bleeding was achieved with sclerotherapy during 197 hospital admissions (92%). Of the 17 failures of emergency sclerotherapy, 4 patients died from uncontrolled bleeding and 13 patients underwent major surgical intervention. Definitive control of variceal bleeding was achieved with a single injection treatment in 138 hospital admissions (70%). Complications were mostly of a minor nature and occurred at a rate of 6% per injection treatment. The overall hospital admission mortality was 36%. The majority of patients died due to liver failure. The mortality in patients who required 4 injection treatments to control variceal bleeding was 71%. Injection sclerotherapy is proposed as the emergency treatment of choice for patients whose variceal bleeding continues or recurs after initial conservative management. Patients whose variceal bleeding is not controlled by 2 injection treatments require more major emergency surgery. Patients who did not have varices and those with varices but who were bleeding from other lesions were excluded from the study. In patients with varices that had stopped bleeding, the vasopressin infusion was continued for 24-48 hours. A SengstakenBlakemore balloon tube was only inserted in those patients with active variceal bleeding at the time of emergency endoscopy. This latter group of patients underwent emergency injection sclerotherapy between 6 and 24 hours after inserting the Sengstaken tube. These 173 patients constitute the present study groups ( Figure   1 ). Resuscitation was continued and liver failure treated with Neomycin and/or Lactulose as required.
INTRODUCTION
Emergency injection sclerotherapy has become firmly established as part of the management of acute variceal haemorrhage, particularly if bleeding does not respond to simple conservative measures1-3. Definitive control of variceal haemorrhage with this form of therapy is reported to be in excess of 90%4-9. This paper reviews the first 10 years of our prospective study of injection sclerotherapy in the emergency management of the subset of bad-risk patients with endoscopically proven active variceal haemorrhage who required Sengstaken balloon tube tamponade for initial control of bleeding. During the 10 Patients who did not have varices and those with varices but who were bleeding from other lesions were excluded from the study. In patients with varices that had stopped bleeding, the vasopressin infusion was continued for 24-48 hours. A SengstakenBlakemore balloon tube was only inserted in those patients with active variceal bleeding at the time of emergency endoscopy. This latter group of patients underwent emergency injection sclerotherapy between 6 and 24 hours after inserting the Sengstaken tube. These 173 patients constitute the present study groups ( Figure   1 ). Resuscitation Patients who only required a single injection sclerotherapy treatment had a mortality of 22% whereas the mortality was 71 when 4 injections were needed (Table 3) . The causes of death are shown in Table 4 . The majority of patients died of liver failure. In 32 patients the liver failure was associated with multiorgan failure. Only 4 patients (2.3%) died as a result of uncontrolled bleeding. This paper highlights other key problems in the management of bleeding varices. First, despite a 92% control of bleeding by sclerotherapy the hospital mortality is still 36% and these patients mainly die of liver failure. The speed of referral to hospital and the amount of blood lost before the patient reaches expert care may be a factor: the geography and an efficient referral and transfer system may partly account for the low in-hospital mortality reported by Johnston 
